Design, Synthesis and Biological Activity of Pyrazolo[3,4-d]pyrimidine Derivatives Containing Indole Moiety

Xiaoyang Sun,Siran Feng,Jinjiao Dong,Jiajia Feng,Zhenming Liu,Yali Song,Xiaoqiang Qiao
DOI: https://doi.org/10.6023/cjoc201907006
2020-01-01
Chinese Journal of Organic Chemistry
Abstract:Based on the combination principle in drug design, thirteen pyrazolo[3,4-d]pyrimidine derivatives containing indole moiety were designed and synthesized. The target compounds were confirmed by 1H NMR, C-13 NMR and HRMS. Their in vitro cytotoxicity against four human cancer cell lines (HeLa, MGC-803, MCF-7, BEL-7404) has been investigated and most of the tested compounds displayed moderate antiproliferative activity. Especially, compound 5m exhibited the highest level of antiproliferative activity with an IC50 value <30 mu mol.L-1 for HeLa, MGC-803 and MCF-7. IC50 value of methyl 344-oxo-l-phenyl-4,5-dihydro-1H-pyrazolo[3,4-d]pyrimidin-6-ypthio)-1H-indole-6-carboxylate (5m) to MCF-7 was (4.02 +/- 0.92) mu mol center dot L-1, which was better than etoposide (10.1 +/- 0.62 mu mol.L-1 ) and camptothecin (5.93 +/- 0.56 mu mol.L-1). Further biological evaluation of these compounds suggested that these compounds showed selective inhibitory activity against Topo II as a possible intracellular target, and all compounds didn't show inhibitory activity against Topo I.
What problem does this paper attempt to address?